Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 2040550

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2040550

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Type of Coating, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Drug Eluting Stent Market Size & Trends:

The global drug eluting stent market size was estimated at USD 4.0 billion in 2025 and is projected to reach USD 6.7 billion by 2033, growing at a CAGR of 6.7% from 2026 to 2033. Market growth is primarily driven by the rising CVD prevalence, fueled by obesity, hypertension, diabetes, aging populations, sedentary lifestyles, and unhealthy diets. In October 2024, the CDC reported 919,032 deaths in the U.S. from cardiovascular disease in 2023, with coronary heart disease causing 371,506 deaths. About 1 in 6 CVD deaths occurred in adults under 65, and approximately 805,000 heart attacks happened nationwide, including 605,000 first-time events.

Rising Prevalence of Cardiovascular Diseases and Associated Risk Factors

The rising prevalence of cardiovascular diseases (CVDs) is a primary driver of the market. Increasing cases of coronary artery disease, heart failure, and peripheral artery disease are largely driven by lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behavior. As the global population ages, the demand for interventional procedures such as stenting, angioplasty, and catheter-based therapies continues to grow. In December 2025, the CDC released the 2024 adult obesity prevalence data for all U.S. states and territories. Obesity, defined as a BMI >=30 kg/m2, increases the risk of chronic diseases such as heart disease, diabetes, and certain cancers. Rates ranged from 25% to over 40%, highlighting the urgent need for prevention and treatment strategies across the population.

Increasing Volume of Percutaneous Coronary Intervention (PCI) Procedures

PCI is widely used to treat coronary artery disease and restore blood flow in narrowed or blocked coronary arteries. The increasing prevalence of cardiovascular diseases, including coronary artery disease and acute coronary syndromes, is raising the number of patients requiring interventional treatment. Higher incidence of risk factors such as hypertension, diabetes, and obesity further contributes to procedural demand. In May 2025, the SCAI Scientific Sessions reported that 408,060 outpatient PCI procedures (2020-2022) were analyzed, with 1.8% performed in ambulatory surgery centers and 98.2% in hospital outpatient departments. PCI use in ASCs rose to 0.87 per 10,000 person years, and 30 day adverse events, including mortality, stroke, and bleeding, remained below 2%.

Global Drug Eluting Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug eluting stents market report based on type of coating, end use, and region:

  • Type of Coating Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Polymer-based Coating
    • Non-biodegradable Polymers
    • Biodegradable Polymers
  • Polymer-free Coating
    • Micro porous Surface
    • Micro structured Surface
    • Slotted tubular Surface
    • Nanoporous Surface
  • End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Cardiac/Vascular Centers
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-999-9

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Drug Eluting Stent Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type of Coating Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Eluting Stent Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
  • 3.3. Global Drug Eluting Stents: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Force Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Country-Level Market Driver Mapping
  • 3.5. Market Entry Attractiveness Assessment

Chapter 4. Drug Eluting Stent Market Segment Analysis, By Type of Coating (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • 4.1. Definition and Scope
  • 4.2. Type of Coating Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Drug Eluting Stents Market By Type of Coating Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 4.5.1. Polymer-based Coating
      • 4.5.1.1. Polymer-based Coating Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.1.2. Polymer-based Coating Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.1.2.1. Non-biodegradable Polymers
          • 4.5.1.2.1.1. Non-biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.1.2.1.2. Non-biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.1.2.2. Biodegradable Polymers
          • 4.5.1.2.2.1. Biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.1.2.2.2. Biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 4.5.2. Polymer-free Coating
      • 4.5.2.1. Polymer-free Coating Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.2.2. Polymer-free Coating Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.1. Micro Porous Surface
          • 4.5.2.2.1.1. Micro Porous Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.1.2. Micro Porous Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.2. Micro Structured Surface
          • 4.5.2.2.2.1. Micro Structured Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.2.2. Micro Structured Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.3. Slotted Tubular Surface
          • 4.5.2.2.3.1. Slotted Tubular Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.3.2. Slotted Tubular Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.4. Nanoporous Surface
          • 4.5.2.2.4.1. Nanoporous Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.4.2. Nanoporous Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 5. Drug Eluting Stent Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Drug Eluting Stents Market By End Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 5.5.1. Hospitals
      • 5.5.1.1. Hospitals Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.2. Specialty Cardiac/Vascular Centers
      • 5.5.2.1. Specialty Cardiac/Vascular Centers Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.3. Ambulatory Surgical Centers (ASCs)
      • 5.5.3.1. Ambulatory Surgical Centers (ASCs) Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Drug Eluting Stent Market Segment Analysis, By Region, (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Drug Eluting Stents Market Share by Region, 2025 & 2033:
  • 6.5. North America
    • 6.5.1. North America Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. U.S. Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.2.5. U.S. Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Canada Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.3.5. Canada Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Canada Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.4.5. Canada Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6. Europe
    • 6.6.1. Europe Drug Eluting Stents Market, 2021 To 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. UK Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.2.5. UK Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Germany Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.3.5. Germany Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. France Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.4.5. France Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Italy Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.5.5. Italy Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Spain Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.6.5. Spain Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Denmark Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.7.5. Denmark Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Sweden Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.8.5. Sweden Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Norway Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.9.5. Norway Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7. Asia Pacific
    • 6.7.1. China
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. China Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.1.5. China Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Japan Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.2.5. Japan Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. India Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.3.5. India Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Australia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.4.5. Australia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. South Korea Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.5.5. South Korea Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Thailand Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.6.5. Thailand Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.7. Indonesia
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Indonesia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.7.5. Indonesia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.8. Malaysia
      • 6.7.8.1. Key Country Dynamics
      • 6.7.8.2. Competitive Scenario
      • 6.7.8.3. Regulatory Framework
      • 6.7.8.4. Malaysia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.8.5. Malaysia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.9. Vietnam
      • 6.7.9.1. Key Country Dynamics
      • 6.7.9.2. Competitive Scenario
      • 6.7.9.3. Regulatory Framework
      • 6.7.9.4. Vietnam Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.9.5. Vietnam Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.8. Latin America
    • 6.8.1. Latin America Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Brazil Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.2.5. Brazil Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Argentina Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.3.5. Argentina Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.4. Colombia
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Colombia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.4.5. Colombia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.5. Chile
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Chile Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.5.5. Chile Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.9. MEA
    • 6.9.1. MEA Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. South Africa Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.2.5. South Africa Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Saudi Arabia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.3.5. Saudi Arabia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. UAE Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.4.5. UAE Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Kuwait Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.5.5. Kuwait Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization (Key innovators, market leaders, emerging players)
  • 7.3. Company Market Position Analysis, 2025
  • 7.4. Company Market Share Analysis, 2025/2026 (%)
  • 7.5. Company Profiles
    • 7.5.1. Boston Scientific Corporation
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Medtronic
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Abbott
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Teleflex Incorporated (BIOTRONIK)
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Terumo Corporation
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. B. Braun SE
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Translumina
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. MicroPort Scientific Corporation
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Biosensors International Group, Ltd
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Lepu Medical
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. iVascular S.L.U.
      • 7.5.11.1. Company Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. SMT
      • 7.5.12.1. Company Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
    • 7.5.13. Meril Life Sciences Pvt. Ltd.
      • 7.5.13.1. Company Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic Initiatives
    • 7.5.14. Concept Medical
      • 7.5.14.1. Company Overview
      • 7.5.14.2. Financial Performance
      • 7.5.14.3. Product Benchmarking
      • 7.5.14.4. Strategic Initiatives
    • 7.5.15. Cardionovum GmbH
      • 7.5.15.1. Company Overview
      • 7.5.15.2. Financial Performance
      • 7.5.15.3. Product Benchmarking
      • 7.5.15.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-999-9

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 North America Drug Eluting Stents Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 North America Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 5 North America Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 6 North America Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 8 U.S. Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 9 U.S. Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 Canada Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 11 Canada Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 12 Canada Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 14 Mexico Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 15 Mexico Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Europe Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 17 Europe Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 18 Europe Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 19 Europe Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 UK Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 21 UK Drug Eluting Stents Market, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 22 UK Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 24 Germany Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 25 Germany Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 France Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 27 France Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 28 France Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 Italy Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 30 Italy Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 31 Italy Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Spain Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 33 Spain Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 34 Spain Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 35 Denmark Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 36 Denmark Drug Eluting Stents Market Estimates and, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 37 Denmark Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Sweden Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 39 Sweden Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 40 Sweden Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Norway Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 42 Norway Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 43 Norway Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 47 Asia Pacific Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 China Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 49 China Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 50 China Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 51 Japan Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 52 Japan Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 53 Japan Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 India Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 55 India Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 56 India Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 Australia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 58 Australia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 59 Australia Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 60 South Korea Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 61 South Korea Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 62 South Korea Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Thailand Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 64 Thailand Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 65 Thailand Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Indonesia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 67 Indonesia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 68 Indonesia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Malaysia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 70 Malaysia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 71 Malaysia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72 Vietnam Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 73 Vietnam Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 74 Vietnam Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 Latin America Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 76 Latin America Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 77 Latin America Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 78 Latin America Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Brazil Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 80 Brazil Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 81 Brazil Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 82 Argentina Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 83 Argentina Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 84 Argentina Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 Colombia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 86 Colombia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 87 Colombia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 Chile Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 89 Chile Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 90 Chile Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 MEA Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 92 MEA Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 93 MEA Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 94 MEA Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 95 South Africa Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 96 South Africa Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 97 South Africa Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 98 Saudi Arabia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 99 Saudi Arabia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 100 Saudi Arabia Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 101 UAE Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 102 UAE Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 103 UAE Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Kuwait Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 105 Kuwait Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 106 Kuwait Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling For Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Drug Eluting Stents Market: Market Outlook
  • Fig. 9 Drug Eluting Stents Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Ancillary Market Outlook
  • Fig. 12 Global Drug Eluting Stents Market Driver Impact
  • Fig. 13 Global Drug Eluting Stents Market Restraint Impact
  • Fig. 14 Porter's Five Force's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Drug Eluting Stents Market: Type of Coating Movement Analysis
  • Fig. 17 Drug Eluting Stents Market: Type of Coating Outlook and Key Takeaways
  • Fig. 18 Polymer-based Coating Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 19 Non-biodegradable Polymers Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 20 Biodegradable Polymers Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 21 Polymer-free Coating Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 22 Micro Porous Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 23 Micro Structured Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 24 Slotted Tubular Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 25 Nanoporous Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 26 Drug Eluting Stents Market: End Use Movement Analysis
  • Fig. 27 Drug Eluting Stents Market: End Use Outlook and Key Takeaways
  • Fig. 28 Hospitals Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Specialty Cardiac/Vascular Centers Market Estimates and Forecast, 2021 - 2033
  • Fig. 30 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2021 - 2033
  • Fig. 31 Global Drug Eluting Stents Market: Regional Movement Analysis
  • Fig. 32 Global Drug Eluting Stents Market: Regional Outlook and Key Takeaways
  • Fig. 33 North America Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 34 Key Country Dynamics
  • Fig. 35 U.S. Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 36 Key Country Dynamics
  • Fig. 37 Canada Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 38 Key Country Dynamics
  • Fig. 39 Mexico Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 40 Europe Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 41 Key Country Dynamics
  • Fig. 42 UK Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 Germany Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 France Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Italy Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Spain Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Denmark Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 Sweden Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 55 Norway Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (USD million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Asia Pacific Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 China Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Japan Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 India Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Australia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 South Korea Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Thailand Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Indonesia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Malaysia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Vietnam Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Latin America Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Brazil Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 Argentina Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 Colombia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 Chile Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 MEA Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 South Africa Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Saudi Arabia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 UAE Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Kuwait Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Key company categorization
  • Fig. 98 Heat map analysis 2025
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!